Lyphe Australia Brand Profile
Lyphe Group is a patient-centred medicinal cannabis access company, dedicated to bringing medical cannabis treatments to patients with unmet clinical needs.
At Lyphe Group we believe all patients with unmet clinical needs should be able to access medicinal cannabis. Lead by the experts, guided by science and dedicated to improving people’s lives, The Lyphe Group is trusted by regulators, Governments, the public and our partners to open up access to medical cannabis for patients across the world.
Lyphe Australia Product List
Validation required for access - please validate your medAuth account. If already validated, please sign out of Canna Reviews, and sign back in again.
Swipe left on table to view more detail.
Form | Product Name | Size | THC | CBD | Feedback | Response | Price |
---|---|---|---|---|---|---|---|
Aelleve Balance10 | 30ml | 10mg/ml | 10mg/ml | 0 | 0 | $90 | |
Aelleve Balance25 | 30ml | 25mg/ml | 25mg/ml | 0 | 0 | $120 | |
Aelleve T26 | 30ml | 26mg/ml | <1mg/ml | 0 | 0 | $80 | |
Aelleve CBD100+ | 30ml | 0mg/ml | 100mg/ml | 0 | 0 | $130 | |
Aelleve WF THC20 LL | 10g | 20% | <1% | 2 | 2.8 | $105 | |
Aelleve WF THC24 GTH | 10g | 24% | <1% | 3 | 4.0 | $130 | |
Aelleve Day Live Rosin Cart | 0.5g | 350mg | <0.1mg | 0 | 0 | $80 | |
Aelleve Night Live Rosin Cart | 0.5g | 350mg | <0.1mg | 0 | 0 | $85 | |
Aelleve WF THC24 MK | 10g | 24% | <1% | 0 | 0 | $115 | |
Aelleve Access 22 Indica | 10g | 22% | <1% | 2 | 2.8 | $70 | |
Aelleve Access 22 Sativa | 10g | 22% | <1% | 4 | 3.8 | $70 |
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC. CANNABIS IS A SCHEDULED AND REGULATED DRUG.
The information above is not to be taken as medical advice. Cannabis may have negative side effects or interactions with other medications. Medical Cannabis is not effective for everyone and more research needs to be done. Please consult a health professional for advice. Canna Reviews does not receive financial incentives or compensation for displaying product information.